UPDATE: Horizon Pharma (HZNP) Files $175M Mixed Shelf
Tweet
Share
E-mailGet Alerts HZNP Hot Sheet
Join SI Premium – FREE
(Updated - August 1, 2012 8:36 AM EDT)
Horizon Pharma (Nasdaq: HZNP) filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to $175 million of Common Stock, Preferred Stock, Debt Securities, Warrants, or any combination thereof.
Horizon Pharma (Nasdaq: HZNP) filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to $175 million of Common Stock, Preferred Stock, Debt Securities, Warrants, or any combination thereof.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Matinas BioPharma to merge with GH Power, sell drug unit to Azurity
- Banzai prices $0.9M public offering at $2.75 per share
- Agenus raises up to $340M to fund MSS colon cancer Phase 3 trial
Create E-mail Alert Related Categories
Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
